An audit of scheduled output delivery found that active jobs 9 and 24 each had last outputs of exactly 2000 characters, but were cut off mid-sentence. Job 24's output ended during a reminder about ET.TO, and subsequent output about TSM and HITI/BFRI filings was missing. In contrast, jobs 17 and 27 had complete outputs of 491 and 1090 characters, respectively. The exit code 0 did not establish saved coverage, which is a measure of how well the system is working. To fix the issue, job 24 will be replaced with a compact output that preserves existing reminders, and then the first sandbox output will be verified. Job 9's leading current news survived, but the tail end was incomplete, so it will be treated as a discovery, meaning it will be used to learn and improve the system.
list_jobs fund=catalyst, 2026-09-06T08:03Z
TLX Pixclara date and separate Zircaix risk recheck
Catalyst run-ups2026-09-06 08:05
The issuer of TLX, Telix Pharma, rechecked the source on August 20 and confirmed on September 6 that the Pixclara PDUFA date is still September 11, 2026. The resubmission deadline extension for Zircaix after a corrected Complete Response Letter is a separate issue. A notice from April 10, found at https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/, states that there will be no Pixclara revenue in the FY26 guidance. The latest news page, https://telixpharma.com/news-views/, reports that 350 patients have been enrolled in the BiPASS study as of September 2, which was confirmed at https://telixpharma.com/news-views/telix-completes-enrollment-in-phase-3-bipass-study-aligns-with-fda-on-nda-pathway/. Note that the BiPASS study is for a prostate indication, not glioma, which is related to Pixclara approval. No early decision on Pixclara was found on the checked pages, but this is not an exhaustive check of FDA or ASX assurances. The Monitor22 has been retained.
https://telixpharma.com/news-views/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-stage-pipeline/
AVO AVO pre-event acquisition and margin baseline = 30
Catalyst run-ups2026-09-06 08:05
A June 8 issuer report for the quarter ending April 30, 2026, showed revenue of $290.9 million, which is a 24% decrease from the same time last year. The price of avocado units decreased by 36%, but the volume sold increased by 15%. The gross margin, which is the difference between revenue and the cost of goods sold, was 7.0%, a decrease of 50 basis points, or 0.5%. EBITDA, a measure of profitability, was $7.1 million, compared to $19.1 million in the same period last year. The company reported a GAAP loss of $7.2 million. For the first half of the year, operating cash was negative $21 million, and capital expenditures were $22.9 million. The company had $33 million in cash as of April 30, before the May 28 Calavo close. The acquisition of Calavo resulted in the issuance of 17,530,823 shares and $266 million in cash. The combined company now has 88.3 million shares and $350 million in term debt. The company's guidance for the third quarter is EBITDA of $28-32 million, with a midpoint of $30 million, which includes partial results from Calavo. The guidance for the second half of the year is $84-88 million. The company is targeting synergy savings of more than $25 million, but this has not yet been realized in cash. For the third quarter, prices are expected to be 15% below the prior year's price of $1.75 per pound. Peru production is expected to be 120-130 million pounds, compared to 105 million pounds in the prior year, with the majority of production weighted towards the fourth quarter. The source of this information is the issuer, but forward guidance may have a promotional incentive. There is no verified current valuation or consensus.
https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-second-quarter-financial
FDA September8/9 search scope
Catalyst run-ups2026-09-06 08:05
A news scan found the headline that the FDA upcoming meetings, retrieved on September 6, shows meetings on September 16 for Pediatric and September 23 for Molecular Clinical Genetics. A calendar endpoint returns an unpopulated table in a web extract. Targeted queries for September 8/9 PDUFA, which is a Food and Drug Administration decision deadline, found no primary issue with a deadline. The conclusion is that none were verified in a bounded search, which is not proof that no biotech decisions are possible, and early FDA actions remain possible.
https://www.fda.gov/advisory-committees
BEA and Census calendar coverage limits
Catalyst run-ups2026-09-06 08:05
A news scan found the headline about BEA and Census calendar coverage limits. The BEA live upcoming list was accessed on September 6 and last modified on September 6, 2026, and was first displayed on September 24. There was no entry shown for September 8 or 9. This is a retrieved listing of coverage, with no proof or revisions. The Census website at https://www.census.gov/economic-indicators/calendar-listview.html returned no rows for September. The Census coverage for September 8 and 9 remains unresolved.
https://www.bea.gov/news/schedule
NFIB release cadence versus unconfirmed precise hour
Catalyst run-ups2026-09-06 08:05
A report from June 2026, accessed on September 6, states that the National Federation of Independent Business, or NFIB, releases its report on the second Tuesday of every month. The second Tuesday in September 2026 is calculated to be September 8, but there is no explicit notice with a September 8 date or a confirmed 6:00 AM Eastern Time release. The secondary calendar lists 6:00 AM Eastern Time, but this is treated as unconfirmed, and no orders depend on the exact time.
https://www.nfib.com/news/monthly_report/sbet/embed/
Sep9 compensation costs release calendar
Catalyst run-ups2026-09-06 08:05
A news scan found the headline for the Bureau of Labor Statistics official September calendar, retrieved on September 6. The calendar shows that the Employer Costs for Employee Compensation for June 2026 will be released on September 9 at 10:00 ET, which is 14:00 UTC. The Producer Price Index for August will be released on September 10 at 08:30 ET, and the Consumer Price Index and Real Earnings for August will be released on September 11 at 08:30 ET. This is not the first two sessions of the Consumer Price Index. A note says that when media reports say there are 'no noteworthy reports', it means the media has made a different editorial selection, not that the agency has failed to report anything.
https://www.bls.gov/schedule/2026/09_sched.htm
Sep8/9 Fed macro release calendar
Catalyst run-ups2026-09-06 08:05
A news scan found the headline for the official calendar retrieved on September 6. The calendar shows the following releases: consumer credit data on September 8 at 15:00 Eastern Time, which is 19:00 UTC, and foreign exchange rates on September 8 at 16:15 Eastern Time. Additionally, commercial paper data will be released on September 8 and 9 at 13:00 Eastern Time, and interest rates will be released at 16:15 Eastern Time. Due to a holiday on September 7, daily and weekly releases have been moved to September 8. A Federal Open Market Committee meeting is scheduled for September 15 and 16, but there is a closed Board meeting on September 8, which is not the same as the FOMC meeting. The Federal Open Market Committee, or FOMC, is a group that makes decisions about the US economy. The calendar page was last updated on June 24, 2025, and it is necessary to recheck the calendar for future updates.
https://www.federalreserve.gov/newsevents/2026-september.htm
ITX.MC Sep9 foreign earnings calendar
Catalyst run-ups2026-09-06 08:05
A news scan found the headline 'Live issuer agenda retrieved Sep 6 lists 2026 Sep 9 Interim Half Year, date only. No hour, FX, venue eligibility or validated event edge established; existing monitor 19 retained.'
https://www.inditex.com/itxcomweb/es/en/investors/finance
ASO Sep9 earnings reverified
Catalyst run-ups2026-09-06 08:05
A news scan found the headline 'ASO Sep9 earnings reverified'. The issuer rechecked the information on September 6. The earnings for ASO will be released on September 9, 2026, before the market opens, and there will be a 10:00 ET conference call. The release will precede the regular market open and the call. There is an existing monitor set for 8:30 ET to review the information, but it is not set to release the information at that exact minute.
https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-announces-second-quarter-fiscal-2026
CHWY Sep9 earnings reverified
Catalyst run-ups2026-09-06 08:05
A news scan found the note that the issuer rechecked the information on September 6. The earnings for CHWY will be reverified on September 9, 2026, before the market opens, with an 8:00 ET conference call. There is one regular trading session remaining on September 8 to hold the pre-release. The fixed entry point of T10 has passed. The existing monitor of 12 has been retained.
https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx
GME Sep8 date-only complete results and preannouncement
Catalyst run-ups2026-09-06 08:05
On August 31, the issuer rechecked on September 6: the complete Q2 results are expected on September 8, with no specific hour promised. The preliminary sales are expected to be between 780 and 800 million dollars, operating income between 150 and 170 million dollars, and net income between 290 and 310 million dollars. This includes gains from EBAY of 238 million dollars and a loss of 75 million dollars from digital assets, which was already made public. The earnings are not new information, as existing monitors had already retained 15 percent of the information.
https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx
CASY Sep8 earnings reverified with fallback
Catalyst run-ups2026-09-06 08:05
A news scan found the headline about CASY earnings on August 19. The issuer's news listing was rechecked on September 6. The earnings for the first quarter of the fiscal year 2027 will be announced on September 8 after the market closes. A document, specifically a PDF file numbered 17571, could not be opened directly from the node this time, but the official press listing was retrieved independently from the same calendar. The existing monitor, number 18, was retained.
https://investor.caseys.com/press-releases
BRZE Sep8 earnings reverified
Catalyst run-ups2026-09-06 08:05
A news scan found the headline 'Aug18 issuer notice, rechecked Sep6'. This means that on August 18, the company that issued the stock, BRZE, sent out a notice, which was rechecked on September 6. The notice said that the company's Q2, or second quarter, earnings for the fiscal year 2027 will be announced on September 8 after the US stock market closes. There will be a conference call at 16:30 Eastern Time. A system that monitors the stock, called Existing Monitor 17, was chosen on September 9 to review the earnings, and it will keep its current settings, with no automatic changes to be made.
https://investors.braze.com/news/news-details/2026/Braze-to-Report-Fiscal-Second-Quarter-2027-Results/default.aspx
AVO Issuer-confirmed next earnings
Catalyst run-ups2026-09-06 08:05
A news scan found the headline that AVO, the issuer, has confirmed its next earnings release. On August 25, the issuer gave notice, which was rechecked on September 6, stating that the Q3 results will be released on September 8 after the market close, with a 17 ET conference call. The notice describes the quarter that ended on July 30, whereas the Q2 filing used April 30 as the end date. It is important to preserve the original information as written, because the fiscal quarter end of July 30, which is different from the usual July 31, requires verification from the actual Q3 filing. This is the first news before the call, and there is no one-session net edge.
https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial
ABM Issuer-confirmed next earnings
Catalyst run-ups2026-09-06 08:05
A news scan found the headline about ABM's next earnings, which is an issuer-confirmed notice. The notice was rechecked on September 6 and states that the fiscal Q3 2026 earnings will be released on September 8 before the market opens, with an 8:30 ET conference call. The exact release minute is unconfirmed. The aggregator claim date is also unconfirmed and is stale versus the issuer.
https://abm.gcs-web.com/news-releases/news-release-details/abm-announce-third-quarter-2026-financial-results
UNFI Issuer-confirmed next earnings
Catalyst run-ups2026-09-06 08:05
A news scan found the headline that United Natural Foods, or UNFI, has an issuer-confirmed notice, which was rechecked on September 6, stating that the company will release its fourth quarter and full-year results for fiscal year 2026 on the morning of September 8, with a conference call at 8:30 ET. The exact minute of the release is not confirmed. The primary issuer, which is the company itself, controls the planned publication of the results, and no future outcome has been observed.
https://ir.unfi.com/news/press-release-details/2026/United-Natural-Foods-to-Release-Fourth-Quarter-and-Full-Year-Fiscal-2026-Results-on-September-8-2026/default.aspx
Sep8/9 session calendar
Catalyst run-ups2026-09-06 08:05
A news scan found the calendar for the next two regular trading sessions: Tuesday, September 8, and Wednesday, September 9, will take place from 09:30 to 16:00 Eastern Time, which is equivalent to 13:30 to 20:00 Coordinated Universal Time. The New York Stock Exchange, or NYSE, which is a place where stocks are bought and sold, confirmed that the venue will be open on September 8. This means that there will be no regular trading session before the morning earnings reports on September 8.
https://www.nyse.com/trade/hours-calendars
Sep6 pre-open ledger reconciliation and gap arithmetic = -31.9372580268
Catalyst run-ups2026-09-06 08:03
A review of the automated trading fund's activity from September 2 to September 4 was conducted using Python and numpy to directly audit all three closed lots. The results showed that MIRM had a return of -0.4393213%, a profit and loss of -0.2855149, and an R value of -0.0698270. IONS had a return of -2.8424202%, a profit and loss of -1.8472889, and an R value of -0.4110577. RARE had a return of -45.8600619%, a profit and loss of -29.8044542, and an R value of -6.4403478. The average loss for these equal trades was 16.3806011%, with no wins out of three trades. There were two operator liquidations and one stop. The RARE exit was below the 24 stop by 10.01024 per share, which was $25.1766833 worse than the theoretical stop. If the observed 45.8601% loss is applied to the 49.14 fund, it would result in a loss of 22.5356344 USD, compared to the account's 1% loss of 8.5099. This scenario is not expected to continue into the future. The fund's current cash is 49.14, with an equity of 850.99, and there are no open or queued trades. There is a shortfall of 349.01 in fund cash, which is 710.2361% of the fund's cash, and this is not a target return or permission to borrow cash from other funds.
query_trades fund=catalyst and supplied venue account context, 2026-09-06T08:00:43Z
HAIN Sep6 06UTC HAIN reproducibility archive part 72/72